Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -16.87% is 202% below its 5-year average of -5.59%, near the low end of its 5-year range (-16.87%–-3.46%).
175.20% below its 12-month average of -6.13%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -6.55%.
RETURN ON ASSETS (ROA)
-16.87%
RETURN ON ASSETS (ROA) AVG TTM
-6.13%
RETURN ON ASSETS (ROA) AVG 3Y
-6.48%
RETURN ON ASSETS (ROA) AVG 5Y
-5.59%
RETURN ON ASSETS (ROA) AVG 10Y
-4.72%
RETURN ON ASSETS (ROA) AVG 15Y
-2.33%
RETURN ON ASSETS (ROA) AVG 20Y
1.47%
CURRENT VS TTM AVG
-175.20%
CURRENT VS 3Y AVG
-160.24%
CURRENT VS 5Y AVG
-201.79%
CURRENT VS 10Y AVG
-257.76%
CURRENT VS 15Y AVG
-625.40%
CURRENT VS 20Y AVG
-1245.76%
SECTOR MEDIAN · HEALTHCARE
-31.94%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
+47.18%
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$109.38M
Return on Assets (ROA)
-16.87%
TTM Avg
-6.13%
3Y Avg
-6.48%
5Y Avg
-5.59%
Market Cap
$109.74M
Return on Assets (ROA)
-14.14%
TTM Avg
-26.48%
3Y Avg
-30.34%
5Y Avg
-26.58%
Market Cap
$107.17M
Return on Assets (ROA)
-233.43%
TTM Avg
-298.69%
3Y Avg
-252.88%
5Y Avg
-237.20%
Market Cap
$106.93M
Return on Assets (ROA)
-70.09%
TTM Avg
-324.97%
3Y Avg
-229.15%
5Y Avg
-168.27%
Market Cap
$106.91M
Return on Assets (ROA)
-80.25%
TTM Avg
-36.24%
3Y Avg
-78.62%
5Y Avg
-77.58%
Market Cap
$112.41M
Return on Assets (ROA)
-31.75%
TTM Avg
-34.00%
3Y Avg
-32.33%
5Y Avg
-29.29%
Market Cap
$112.51M
Return on Assets (ROA)
-48.90%
TTM Avg
-85.01%
3Y Avg
-256.52%
5Y Avg
-384.82%
Market Cap
$106.07M
Return on Assets (ROA)
-63.19%
TTM Avg
-62.03%
3Y Avg
-51.81%
5Y Avg
-103.22%
Market Cap
$112.69M
Return on Assets (ROA)
-167.64%
TTM Avg
-183.95%
3Y Avg
-119.46%
5Y Avg
-95.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $109.38M | -16.87% | -6.13% | -6.48% | -5.59% |
| Apyx Medical Corporation (APYX)vs › | $109.74M | -14.14% | -26.48% | -30.34% | -26.58% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.17M | -233.43% | -298.69% | -252.88% | -237.20% |
| Immunic, Inc. (IMUX)vs › | $106.93M | -70.09% | -324.97% | -229.15% | -168.27% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | -80.25% | -36.24% | -78.62% | -77.58% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.41M | -31.75% | -34.00% | -32.33% | -29.29% |
| Unicycive Therapeutics, Inc. (UNCY)vs › | $112.51M | -48.90% | -85.01% | -256.52% | -384.82% |
| Vivani Medical, Inc. (VANI)vs › | $106.07M | -63.19% | -62.03% | -51.81% | -103.22% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $112.69M | -167.64% | -183.95% | -119.46% | -95.34% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.94M | -85.80% | -37.85% | -56.27% | -56.27% |
ROA
-16.9%
ROE
-60.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -3.69% |
| 2024-12-31 | -8.57% |
| 2023-12-31 | -7.68% |
| 2022-12-31 | -5.99% |
| 2021-12-31 | -4.15% |
| 2020-12-31 | -3.46% |
| 2019-12-31 | -3.38% |
| 2018-12-31 | -6.18% |
| 2017-12-31 | -8.56% |
| 2016-12-31 | -1.01% |
| 2015-12-31 | 0.80% |
| 2014-12-31 | 2.54% |
| 2013-12-31 | -2.40% |
| 2012-12-31 | 5.93% |
| 2011-12-31 | 5.92% |
| 2010-12-31 | 2.67% |
| 2009-12-31 | 2.98% |
| 2008-12-31 | 15.32% |
| 2007-12-31 | 13.99% |
| 2006-12-31 | 16.63% |
| 2005-12-31 | 19.21% |
